CellVax Therapeutics is a privately-held clinical-stage company active in research, development, and innovation on human immunodiagnostic and autologous anticancer vaccines. CellVax Therapeutics has developed a proprietary autologous tumor cell-based cancer immuno-therapy platform. Pioneer in developing a therapy that aims to stimulate the immune system to recognize the abnormality of tumor cells and destroy them, the autologous cell vaccine is made from the tumor cells of the patient and generates a strong immune response.